Gloo Holdings (GLOO) announced that after its initial public offering closed on November 20, 2025, the underwriters partially exercised their option to buy an additional 684,688 shares of Class A common stock at the public offering price of $8.00 per share, less underwriting discounts and commissions.The offering originally comprised 9,100,000 shares; a registration statement became effective on November 18, 2025. Roth Capital Partners served as sole book-running manager, with five co-managers named. Copies of the final prospectus are available from Roth Capital Partners.

Ameren Missouri (NYSE: AEE) said the Missouri Public Service Commission approved a new large-load user rate structure on November 24, 2025 under the Powering Missouri Growth Plan. The approval requires new high-usage customers to pay 100% of direct interconnection costs and provide upfront collateral equal to two years of minimum monthly bills. Key rules include no rate discounts, a minimum monthly demand charge of 80% of requested demand, and required contracts of 12–17 years. The plan supports up to 2 GW of new demand by 2032 and includes revenue-sharing protections for other customers.

Elemental Royalty (NASDAQ: ELE) announced that its common shares will commence trading on the Nasdaq Capital Market at market open on November 25, 2025, while continuing to trade on the TSX Venture Exchange under the same ticker ELE.The company said the Nasdaq listing is expected to improve trading liquidity, broaden exposure to U.S. institutional and retail investors, increase coverage from U.S. investment banks, and create opportunities for potential index inclusion. Concurrently, Elemental shares will cease to be quoted on the OTCQX Best Market. No new shares were issued and the listing does not involve any concurrent financing.

GeoPark (NYSE: GPRK) reported certified PRMS reserves as of Dec 31, 2025 with 2P reserves of 121.3 mmboe (up 38% YoY) and a 2P Reserve Life Index of 12.7 years. The company cited a 2P Reserve Replacement Ratio of 430% after adding 36.7 mmboe from its Vaca Muerta acquisition. GeoPark disclosed a 2P NPV10 after tax of $1.3 billion and a net debt-adjusted 2P value per share of $15.8. Reported 2025 FD&A cost on a 2P basis was $4.3 per boe. Plans include a 2026 drilling program to pursue a 20,000 boepd plateau by 2028.

SANTA CLARA, Calif., Nov. 24, 2025/ PRNewswire/-- Tuya Inc., a global leading AI cloud platform service provider, today announced its unaudited financial results for the third quarter ended September 30, 2025.. Total revenue was US $82.5 million, up approximately 1.1% year-over-year. Platform-as-a-service revenue was US $59.2 million, up approximately 2.4%...

urban-gro (Nasdaq:UGRO) received a Nasdaq determination letter dated November 24, 2025, notifying the company that its failure to timely file the Form 10-Q for the period ended September 30, 2025 is an additional basis for delisting under Nasdaq Listing Rule 5250(c)(1).A Nasdaq Hearings Panel previously granted continued listing on condition the company regains compliance with the Timely Filing Requirement, maintains $2.5 million stockholders' equity by December 31, 2025, and achieves a $1.00 bid price by January 28, 2026. The Panel asked for the company’s written views by November 25, 2025, and urban-gro intends to submit them. There is no assurance the company will regain compliance.

Bristol Myers Squibb (NYSE: BMY) announced that on November 24, 2025 the European Commission approved Breyanzi (lisocabtagene maraleucel) for adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two prior systemic therapies including a BTK inhibitor. Approval covers EU member states and EEA countries Iceland, Norway and Liechtenstein.Approval is based on TRANSCEND MCL results: overall response rate 82.7%, complete response 71.6%, and 50.8% of patients still in response at 24 months. Safety was consistent with known profile; most CRS and neurologic events occurred early and resolved.

SunPower (Nasdaq: SPWR) received a deficiency notice from Nasdaq Listing Qualifications on Nov 19, 2025 for failing to timely file its Q3 Form 10-Q for the quarter ended Sept 28, 2025. The company filed a Form 12b-25 on Nov 12, 2025 explaining the delay to allow more time to compile certain information. Under Nasdaq rules, the company has 60 calendar days from the notice to submit a plan to regain compliance. SunPower anticipates filing the Q3 Form 10-Q during the week of Nov 24, 2025.

Bed Bath & Beyond (NYSE: BBBY) agreed to acquire The Brand House Collective (Nasdaq: TBHC) in a stock-for-stock merger announced Nov 24, 2025. The deal implies an equity value of ~$26.8 million based on Nov 21, 2025 closing prices, with an exchange ratio of 0.1993 BBBY shares per TBHC share. Bed Bath & Beyond currently holds ~40% of TBHC and advanced $10 million to TBHC for store conversions. The combined company expects to unlock at least $20 million in cost eliminations, close >40 underperforming stores in early 2026, and target closing in Q1 2026, subject to shareholder and lender approvals.

Exact Sciences (Nasdaq: EXAS) will present 10 abstracts at the 2025 San Antonio Breast Cancer Symposium, Dec 9-12, highlighting clinical validation and real‑world data across its Precision Oncology portfolio.Key items include the first clinical validation of the Oncodetect test in triple‑negative breast cancer with highly sensitive MRD detection, a large ongoing NSABP B‑64 trial enrolling >1,800 patients with readouts starting in 2027, and multiple Oncotype DX studies showing improved outcomes, guideline‑concordant use across racial and ethnic groups, and an estimated >€60M chemotherapy cost savings in Ireland.

XMax (NASDAQ: XWIN) announced a US$5,000,000 convertible promissory note issued to Billiongold Holding Limited on November 18, 2025. The note matures 36 months after funding, bears interest at 6% per annum, and is convertible at the holder's option into common stock at US$7.80 per share any time before full repayment. The financing was completed in a transaction exempt from registration under Regulation S of the U.S. Securities Act of 1933.This provides near-term liquidity while creating potential share issuance if the holder converts the note.

Rocket Lab (Nasdaq: RKLB) announced the launch window for its mission “RAISE And Shine”, the first of two dedicated Electron launches contracted directly with the Japan Aerospace Exploration Agency (JAXA).The mission will lift from Rocket Lab Launch Complex 1 in New Zealand and the launch window opens on December 5, 2025 (UTC). It will deploy JAXA’s RAISE-4 single satellite to demonstrate eight technologies from Japanese companies, universities, and research institutions. A second dedicated Electron for the same JAXA program is scheduled for Q1 2026. This flight is slated to be Rocket Lab’s 19th launch in 2025, reflecting an increasing Electron launch cadence.

Record Fiscal Year Results, with Net Income of $305.9 million , up 17% Quarterly Net Operating Revenues of $585.1 million , up 29% Record Quarterly Net Income of $85.7 million , Quarterly ROE of 15.2% Quarterly Diluted EPS of $1.57 per share, Fiscal Year of $5.89 per share NEW YORK, Nov. 24, 2025

Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today confirmed that it has

Nanobiotix (NASDAQ: NBTX) reported a third-quarter 2025 operational and financial update and a 2026 clinical outlook. Key items include a $50 million upfront royalty financing with HealthCare Royalty (HCRx) and an expected additional $21 million contingent payment in one year, €20.4 million cash at Sept 30, 2025, and projected cash visibility into early 2028 assuming receipt of HCRx funds. The company completed majority-region sponsorship transfer of the Phase 3 NANORAY-312 head and neck study to Johnson & Johnson, advanced the JNJ-1900 (NBTXR3) program with Phase 1 esophageal data presented, and expanded Curadigm Nanoprimer IP and preclinical work with collaborations and CMC activities.

Agilent (NYSE: A) reported Q4 FY2025 revenue $1.86B, up 9.4% reported and up 7.2% on a core basis versus Q4 2024, with GAAP EPS of $1.53 (up 25% YoY) and non-GAAP EPS of $1.59 (up 9% YoY). Full FY2025 revenue was $6.95B, up 6.7% reported; FY2025 GAAP EPS was $4.57 and non-GAAP EPS was $5.59. Management provided FY2026 guidance of $7.3B–$7.4B revenue (up 5%–7% reported) and non-GAAP EPS $5.86–$6.00; Q1 FY2026 revenue guidance is $1.79B–$1.82B with non-GAAP EPS $1.35–$1.38.

PennantPark Floating Rate Capital (NYSE: PFLT) reported results for the quarter and fiscal year ended September 30, 2025. Key metrics: investment portfolio $2,773.3M, net assets $1,074.5M, NAV per share $10.83 with a -1.2% quarterly NAV change. Quarterly net investment income was $27.5M ($0.28/sh) and fiscal year NII was $107.2M ($1.16/sh). Weighted average yield on debt investments was 10.2%. Portfolio net unrealized depreciation was $46.1M. The company invested $1,741.3M during the year and issued 21.638M shares via ATM, raising $244.8M. A conference call is scheduled for Nov 25, 2025 at 9:00 AM ET.

Third quarter total revenue of $1,229.8 million , up 4.4% year over year as reported and 4.2% in constant currency Third quarter Enterprise revenue of $741.4 million , up 6.1% year over year Third quarter GAAP operating margin of 25.2% and non-GAAP operating margin of 41.2% Third quarter operating

Fluence Energy, Inc. (Nasdaq: FLNC) (“Fluence” or the “Company”), a global market leader delivering intelligent energy storage, operational services, and asset optimization software, today announced its results for the three months and full fiscal

Exodus Movement (NYSE American: EXOD) announced a definitive agreement to acquire W3C Corp, parent of Monavate and Baanx, adding end-to-end card and payments infrastructure to its self-custodial crypto platform. The deal positions Exodus to control on-chain payments from wallets to cards, support payment stablecoins, and issue cards via Visa, Mastercard, and Discover across the US, UK, and EU. Stablecoin payment volumes rose 70% from Feb–Aug 2025 (two-thirds B2B). XO Swap represented 37% of exchange provider volume in October 2025. The acquisition is subject to regulatory approvals and will integrate issuing, processing, and regulatory capabilities into Exodus’ consumer and enterprise products.